Yervoy, a Melanoma Drug, Wins F.D.A. Approval - NYTimes.com
The first drug shown to prolong the lives of people with the skin cancer melanoma won approval from the FDA on Friday. The drug, Yervoy, was developed by Bristol-Myers Squibb and is a novel type of cancer drug that works by unleashing the body’s own immune system to fight tumors.
